Under construction – not a live service
Sign in
Taking people in ChinaNo phase

Diagnosis and Prognosis for Aortic Aneurysm aNd Dissection in Anzhen(DPANDA) Study

Key facts

Where
Beijing, ChinaSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 80 years old?

Source: NCT03233087, who can take part

Where in China

  • Beijing Anzhen HospitalBeijing, ChinaContact: Yuan WANG, PhDTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
Beijing Institute of Heart, Lung and Blood Vessel Diseases
Trial code
NCT03233087
Record updated
27 June 2024
Original description
The registry study aims to determine serial biomarkers to diagnosis and prognosis of aortic aneurysm/aortic dissection.Read full original descriptionShow less

Diagnosis and Prognosis for Aortic Aneurysm aNd Dissection in Anzhen

The registry study aims to determine serial biomarkers to diagnosis and prognosis of aortic aneurysm/aortic dissection.

Inclusion: Retrospective; All patients who were referred to the surgical service for evaluation and management of aortic dissection were included; Perspective; Patients with initial suspicion of having AAD were perspectively enrolled.

Exclusion: Patients who entered the hospital for checkups after surgery; Perspective; Patients with aortic trauma, pseudo aneurysm, history of heart failure, renal dysfunction, severe pulmonary diseases, or active cancer; Patients in whom there is little or no suspicion of a life-threatening disease; Patients with confirmed acute myocardial infarction,angina or pulmonary embolism; The symptoms were clearly not related to AD (e.g. pleurisy, pneumonia, acute abdominal diseases); Patients who received packed red blood cells, whole blood, or platelets less than 10 days before the blood sample was taken; Retrospective.

ClinicalTrials.gov NCT03233087